<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>82(4)</volume><submitter>Wong A</submitter><journal>Journal of acquired immune deficiency syndromes (1999)</journal><pagination>e47-e49</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6830961</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Efficacy and Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) in Treatment-Naive Adults With HIV-1 and Transmitted Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations.</pubmed_title><pmcid>PMC6830961</pmcid><pubmed_authors>Hepler D</pubmed_authors><pubmed_authors>Rodgers A</pubmed_authors><pubmed_authors>Mallolas J</pubmed_authors><pubmed_authors>Johnson M</pubmed_authors><pubmed_authors>Pozniak A</pubmed_authors><pubmed_authors>Teal V</pubmed_authors><pubmed_authors>DeJesus E</pubmed_authors><pubmed_authors>Sklar P</pubmed_authors><pubmed_authors>Badshah C</pubmed_authors><pubmed_authors>Kumar S</pubmed_authors><pubmed_authors>Molina JM</pubmed_authors><pubmed_authors>Goldstein D</pubmed_authors><pubmed_authors>Hwang C</pubmed_authors><pubmed_authors>Teppler H</pubmed_authors><pubmed_authors>Wong A</pubmed_authors><pubmed_authors>Hanna GJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Efficacy and Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) in Treatment-Naive Adults With HIV-1 and Transmitted Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations.</name><description/><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Dec</publication><modification>2026-04-18T15:22:15.212Z</modification><creation>2025-04-06T02:09:23.401Z</creation></dates><accession>S-EPMC6830961</accession><cross_references><pubmed>31425317</pubmed><doi>10.1097/QAI.0000000000002153</doi></cross_references></HashMap>